1. Srdan (Serge) Verstovsek M.D., Ph.D. Professor of Medicine Department of Leukemia University of Texas MD Anderson Cancer Center Houston, Texas, USA ASH 2012: New JAK Inhibitors…

Slide 1Patient Management Issues in Menopause A CME Slide Library From the Council on Hormone Education Slide 2 Patient Management Issues in Menopause Section 1: Appropriate…

Slide 11 US Investigator Meeting DIAS-4, Chicago, July 2011 DIAS 3&4 Investigational Medicinal Products (IMP) Slide 2 US Investigator Meeting DIAS-4, Chicago, July 2011…

Slide 1Basic Concepts, Practical Issues and Statistical Methods in Bridging Studies Shein-Chung Chow, Ph.D. Professor Department of Biostatistics & Bioinformatics Duke…

Slide 1THE STAKE : 10 MIO POTENTIAL CUSTOMERS IN EUROPE Population of Western Europe ± 325 Mio Number of withdrawals/ year (±4%) (±4%) Number of alcohol dependent ± 10…

1. Fidaxomicin versusVancomycin for ClostridiumDifficile InfectionN Engl J Med 2011:364:422-31Authors: Louie TJ, Miller MA, Mullane KM et. al.Joy A. Awoniyi, PharmD Candidate…

1. Apricus Biosciences, Inc. Corporate presentation2011 Bio International Convention,June 27 ‐30, Washington, DC1 2. Safe‐Harbor StatementStatements under the Private Securities Litigation Reform Act, as amended: With the …

1. The UK Prospective Diabetes Study ukpds 2. • 20-year multicenter RCT -Interventional Trial from 1977 to 1997 • Intensive diabetes control and reduction in complications…

1. DIAN-TU treatment trial Dr Christopher Lane Clinical Research Associate, Dementia Research Centre 2. Overview • What has the DIAN –L study taught us? • DIAN –…

1. TheWestern Norway B-Vitamin Intervention Trial(WENBIT) Ebbing M, Bleie Ø, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering…